Eton Pharmaceuticals Inc. (ETON) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Join SI Premium – FREE
Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of $0.04, $0.07 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $22.5 million versus the consensus estimate of $20.27 million.
For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lucid Capital Markets Starts Turn Therapeutics (TTRX) at Buy
- NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
- Active options: AMD SPCX CRWV AVGO MSTR GOOG SOFI NFLX GME MCD
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
